Our results demonstrated that TAM treatment could rescue AQP3 expression in different models of renal fibrosis (e.g., rats subjected to UUO and TGF-β-exposed human PCKS) as well as in rats with LiCl-induced NDI. The gene discussed is TGFB1; the disease is renal fibrosis.